Hepatocyte Growth Factor and Cardiovascular Autonomic Function

This study has been completed.
Sponsor:
Information provided by:
Oita Red Cross Hospital
ClinicalTrials.gov Identifier:
NCT00478127
First received: May 23, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

In this study, we tested the hypothesis that elevated HGF is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients not receiving insulin treatment.


Condition
Type-2 Diabetes

Study Type: Observational
Study Design: Allocation: Random Sample
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Oita Red Cross Hospital:

  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Type-2 diabetes

Exclusion Criteria:

  • Type-1 diabetes
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00478127

Sponsors and Collaborators
Oita Red Cross Hospital
Investigators
Principal Investigator: Futoshi Anan Oita Red Cross Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00478127     History of Changes
Other Study ID Numbers: AO-272
Study First Received: May 23, 2007
Last Updated: May 23, 2007
Health Authority: Japan: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus, Type 2
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on April 20, 2014